Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...
Starting Jan. 1, 2026, Pennsylvania will limit GLP‑1 weight‑loss drugs under Medicaid — threatening access for thousands of ...
Berberine is an alkaloid compound found in plants with over 400-500 species. It has recently become popular as a potential ...
Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...
The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond current GLP-1 medications.
Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...